CARGO Therapeutics, Inc. (CRGX)
(Delayed Data from NSDQ)
$18.86 USD
+1.07 (6.01%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $18.82 -0.04 (-0.21%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CRGX 18.86 +1.07(6.01%)
Will CRGX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CRGX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRGX
What Makes CARGO Therapeutics, Inc. (CRGX) a New Buy Stock
Wall Street Analysts See a 56.26% Upside in CARGO Therapeutics, Inc. (CRGX): Can the Stock Really Move This High?
CRGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Company News for Mar 25, 2024
Alexandria (ARE) to Post Q4 Earnings: What's in the Cards?
Alexandria (ARE) Inks Leases at its Campuses Amid Solid Demand
Other News for CRGX
CRGX Stock Earnings: Cargo Therapeutics Beats EPS for Q2 2024
Truist Financial Reaffirms Their Buy Rating on CARGO Therapeutics, Inc. (CRGX)
CARGO Therapeutics GAAP EPS of -$1.02
CARGO Therapeutics Inc trading resumes
CARGO Therapeutics Inc trading halted, volatility trading pause